Analyze Diet
The Veterinary record2011; 168(4); 101a; doi: 10.1136/vr.c5289

Acquired antimicrobial resistance in equine Rhodococcus equi isolates.

Abstract: No abstract available
Publication Date: 2011-01-21 PubMed ID: 21257598DOI: 10.1136/vr.c5289Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Boyen F, Pasmans F, Haesebrouck F. (2011). Acquired antimicrobial resistance in equine Rhodococcus equi isolates. Vet Rec, 168(4), 101a. https://doi.org/10.1136/vr.c5289

Publication

ISSN: 2042-7670
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 168
Issue: 4
Pages: 101a

Researcher Affiliations

Boyen, F
  • Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium. filip.boyen@ugent.be
Pasmans, F
    Haesebrouck, F

      MeSH Terms

      • Actinomycetales Infections / drug therapy
      • Actinomycetales Infections / microbiology
      • Actinomycetales Infections / veterinary
      • Animals
      • Anti-Bacterial Agents / pharmacology
      • Anti-Bacterial Agents / therapeutic use
      • DNA, Bacterial / analysis
      • Dose-Response Relationship, Drug
      • Drug Resistance, Bacterial / genetics
      • Horse Diseases / drug therapy
      • Horse Diseases / microbiology
      • Horses
      • Microbial Sensitivity Tests / veterinary
      • Point Mutation
      • Rhodococcus equi / drug effects
      • Rhodococcus equi / isolation & purification
      • Rifampin / pharmacology
      • Rifampin / therapeutic use

      Citations

      This article has been cited 4 times.
      1. Álvarez-Narváez S, Giguère S, Anastasi E, Hearn J, Scortti M, Vázquez-Boland JA. Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi.. mBio 2019 Oct 15;10(5).
        doi: 10.1128/mBio.02260-19pubmed: 31615959google scholar: lookup
      2. Fenton CS, Buckley TC. Minimum inhibitory concentrations of erythromycin and rifampin for Rhodococcus equi during the years 2007-2014.. Ir Vet J 2015;68:23.
        doi: 10.1186/s13620-015-0051-4pubmed: 26445669google scholar: lookup
      3. Schlusselhuber M, Torelli R, Martini C, Leippe M, Cattoir V, Leclercq R, Laugier C, Grötzinger J, Sanguinetti M, Cauchard J. The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.. Antimicrob Agents Chemother 2013 Oct;57(10):4615-21.
        doi: 10.1128/AAC.02044-12pubmed: 23817377google scholar: lookup
      4. Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J. In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.. Antimicrob Agents Chemother 2012 Apr;56(4):1749-55.
        doi: 10.1128/AAC.05797-11pubmed: 22232283google scholar: lookup